THC is the main psychoactive component in Cannabis sativa (marijuana). Because of its mind-altering effects, marijuana is one of the most extensively used illicit drugs worldwide. Cannabis and its active components have received scientific interest in recent years due to changing public attitudes towards drug policy reform. The history, science, and current situation of THC will be covered in this article.
History of THC
Ancient Chinese manuscripts from 2737 BCE mention Cannabis sativa as a therapeutic herb. Many cultures in Asia, Africa, and Europe employed the plant. Recreational use did not become prevalent until the 20th century due to early half-century prohibition legislation. Researchers were wary of studying banned substances under regulatory scrutiny, therefore cannabis research decreased.
In the mid-1960s, scientists began investigating THC fully. At Hebrew University in Jerusalem, scientist Raphael Mechoulam discovered THC from cannabis in 1964. In 1965, his team synthesised pure THC, enabling additional research. Medical practitioners were intrigued by THC’s potential to cure cancer chemotherapy nausea and glaucoma-induced ocular pressure.
The THC science
THC affects our minds and bodies by interacting with cannabinoid receptors. Our body creates endocannabinoids that bind to these receptors to control mood, memory, appetite, sleep, pain, and immune system response. THC mimics natural endocannabinoids but is stronger. They activate the same receptors, creating different moods depending on dosage.
CB1 and CB2 are the primary cannabinoid receptors. The brain and central nervous system have most CB1 receptors, while the peripheral nervous system and immune cells have most CB2 receptors. Smoking, vaping, ingesting, or other methods release THC into the circulation, which diffuses over cell membranes and reaches the brain in seconds. Once there, THC binds to CB1 receptors, starting signalling cascades with immediate and long-term effects.
Short-term effects
THC first induces euphoria, relaxation, and pleasure. Users describe expanded senses, sensuality, music appreciation, and creativity. Initial cognitive impairment may include short-term memory loss, slower reasoning, and altered perception. Other adverse effects include dry mouth, red eyes, and mild anxiousness. Paranoia, disorientation, hallucinations, and psychosis can occur with higher doses.
Long-term effects
THC is metabolised within hours, but regular use might have long-term effects. Chronic users may develop tolerance, dependency, withdrawal, diminished motivation, and despair and anxiety. Combustible smoke inhalation can cause respiratory and cardiovascular issues with prolonged exposure. Some research relate chronic marijuana use to reduced IQ and schizophrenia risk.
Debates & Legal Status
The US Drug Enforcement Administration (DEA) classifies marijuana as a Schedule I drug having no medicinal value and high abuse potential. However, numerous US states and nations including Canada, Uruguay, and Spain have legalised adult-use marijuana, medical cannabis, or personal amounts. Changing public opinion and empirical evidence supporting THC’s usefulness for some diseases drove these changes.
Critics believe that we need more conclusive clinical trials before making any substantial policy changes since small sample sizes, lack of placebo control groups, confounding variables, and varied definitions of “medical” vs. “non-medical” use may bias the data. They also argue that marijuana should be regulated like alcohol and nicotine since it impacts cognition and behaviour.
Conclusion
In summary, THC, a strong chemical component found only in Cannabis Sativa, binds to human cannabinoid receptors to cause psychoactivity. While its legal status is still debated, ongoing research into its pharmacology, toxicity, and possible therapeutic uses suggests that THC should be explored further in cannabinoid therapy development.